Evaluating the Efficacy and Safety of Metformin in Vitiligo
Status:
Not yet recruiting
Trial end date:
2023-11-01
Target enrollment:
Participant gender:
Summary
Metformin modulates metabolism in multiple cell types and is currently used to reduce glucose
levels and insulin resistance in diabetic patients. We hypothesize that oral metformin can
regulate the metabolism of CD8+ T cells, reduce their cytotoxic activity and thus serve as a
novel treatment for vitiligo.